Acknowledgement
This research was funded by the Education Department of Liaoning Province (LSNYB201612), National Key Research and Development Program of China (2017YFD0500901).
References
- Binder B, Lackner HK, Poessl BD, Propst E, Weger W, Smolle J, et al. Prevalence of tinea capitis in Southeastern Austria between 1985 and 2008: up-to-date picture of the current situation. Mycoses. 2011;54(3):243-247. https://doi.org/10.1111/j.1439-0507.2009.01804.x
- Bond R, Morris DO, Guillot J, Bensignor EJ, Robson D, Mason KV, et al. Biology, diagnosis and treatment of Malassezia dermatitis in dogs and cats: clinical consensus guidelines of the world association for veterinary dermatology. Vet Dermatol. 2020;31(1):75. https://doi.org/10.1111/vde.12834
- Yin B, Xiao Y, Ran Y, Kang D, Dai Y, Lama J. Microsporum canis infection in three familial cases with tinea capitis and tinea corporis. Mycopathologia. 2013;176(3-4):259-265. https://doi.org/10.1007/s11046-013-9685-5
- Anemuller W, Baumgartner S, Brasch J. Atypical Microsporum canis variant in an immunosuppressed child. J Dtsch Dermatol Ges. 2008;6(6):473-475. https://doi.org/10.1111/j.1610-0387.2007.06458.x
- Ginter-Hanselmayer G, Weger W, Ilkit M, Smolle J. Epidemiology of tinea capitis in Europe: current state and changing patterns. Mycoses. 2007;50 Suppl 2:6-13. https://doi.org/10.1111/j.1439-0507.2007.01424.x
- Verma SB. Emergence of recalcitrant dermatophytosis in India. Lancet Infect Dis. 2018;18(7):718-719. https://doi.org/10.1016/S1473-3099(18)30338-4
- Aneke CI, Otranto D, Cafarchia C. Therapy and antifungal susceptibility profile of Microsporum canis. J Fungi (Basel). 2018;4(3):107. https://doi.org/10.3390/jof4030107
- Ghannoum MA, Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev. 1999;12(4):501-517. https://doi.org/10.1128/cmr.12.4.501
- Vanden Bossche H. Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. Curr Top Med Mycol. 1985;1:313-351. https://doi.org/10.1007/978-1-4613-9547-8_12
- Borgers M, Van den Bossche H, De Brabander M. The mechanism of action of the new antimycotic ketoconazole. Am J Med. 1983;74(1B):2-8.
- Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10(1):57-63. https://doi.org/10.1038/nrg2484
- Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature. 2000;405:827-836. https://doi.org/10.1038/35015701
- Costa V, Angelini C, De Feis I, Ciccodicola A. Uncovering the complexity of transcriptomes with RNA-Seq. J Biomed Biotechnol. 2010;2010:853916.
- Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev. 1999;12(1):40-79. https://doi.org/10.1128/cmr.12.1.40
- Sanati H, Belanger P, Fratti R, Ghannoum M. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei. Antimicrob Agents Chemother. 1997;41(11):1249-6.
- Ghannoum MA, Spellberg BJ, Ibrahim AS, Ritchie JA, Currie B, Spitzer ED, et al. Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole. Antimicrob Agents Chemother. 1994;38(9):2029-2033. https://doi.org/10.1128/AAC.38.9.2029
- Vanden Bossche H, Marichal P, Le Jeune L, Coene MC, Gorrens J, Cools W. Effects of itraconazole on cytochrome P-450-dependent sterol 14 alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans. Antimicrob Agents Chemother. 1993;37(10):2101-2105. https://doi.org/10.1128/AAC.37.10.2101
- Xiao CW, Ji QA, Wei Q, Liu Y, Pan LJ, Bao GL. Digital gene expression analysis of Microsporum canis exposed to berberine chloride. PLoS One. 2015;10(4):e0124265. https://doi.org/10.1371/journal.pone.0124265
- Galani K, Nissan TA, Petfalski E, Tollervey D, Hurt E. Rea1, a dynein-related nuclear AAA-ATPase, is involved in late rRNA processing and nuclear export of 60 S subunits. J Biol Chem. 2004;279(53):55411-55418. https://doi.org/10.1074/jbc.M406876200
- Lepesheva GI, Waterman MR. Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms. Biochim Biophys Acta. 2007;1770(3):407-477.
- Lepesheva GI, Friggeri L, Waterman MR. CYP51 as drug targets for fungi and protozoan parasites: past, present and future. Parasitology. 2018;145(14):1820-1836. https://doi.org/10.1017/s0031182018000562
- Zhang J, Li L, Lv Q, Yan L, Wang Y, Jiang Y. The fungal CYP51s: their functions, structures, related drug resistance, and inhibitors. Front Microbiol. 2019;10:691. https://doi.org/10.3389/fmicb.2019.00691
- Nowosielski M, Hoffmann M, Wyrwicz LS, Stepniak P, Plewczynski DM, Lazniewski M, et al. Detailed mechanism of squalene epoxidase inhibition by terbinafine. J Chem Inf Model. 2011;51(2):455-462. https://doi.org/10.1021/ci100403b
- Zare B, Sepehrizadeh Z, Faramarzi MA, Soltany-Rezaee-Rad M, Rezaie S, Shahverdi AR. Antifungal activity of biogenic tellurium nanoparticles against Candida albicans and its effects on squalene monooxygenase gene expression. Biotechnol Appl Biochem. 2014;61(4):395-400. https://doi.org/10.1002/bab.1180
- Konecna A, Toth Hervay N, Valachovic M, Gbelska Y. ERG6 gene deletion modifies Kluyveromyces lactis susceptibility to various growth inhibitors. Yeast. 2016;33(12):621-632. https://doi.org/10.1002/yea.3212
- Morio F, Pagniez F, Lacroix C, Miegeville M, Le Pape P. Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence. J Antimicrob Chemother. 2012;67(9):2131-2138. https://doi.org/10.1093/jac/dks186
- Xiao CW, Ji QA, Wei Q, Liu Y, Bao GL. Antifungal activity of berberine hydrochloride and palmatine hydrochloride against Microsporum canis -induced dermatitis in rabbits and underlying mechanism. BMC Complement Altern Med. 2015;15(4):177. https://doi.org/10.1186/s12906-015-0680-x
- Ruiz-Herrera J, San-Blas G. Chitin synthesis as target for antifungal drugs. Curr Drug Targets Infect Disord. 2003;3(1):77-91. https://doi.org/10.2174/1568005033342064
- Yang J, Zhang KQ. Chitin synthesis and degradation in fungi: biology and enzymes. Adv Exp Med Biol. 2019;1142:153-167. https://doi.org/10.1007/978-981-13-7318-3_8
- Shen Q, Zheng X, McNutt MA, Guang L, Sun Y, Wang J, et al. NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules. Exp Cell Res. 2009;315(10):1653-1667. https://doi.org/10.1016/j.yexcr.2009.03.007
- Neyer S, Kunz M, Geiss C, Hantsche M, Hodirnau VV, Seybert A, et al. Structure of RNA polymerase I transcribing ribosomal DNA genes. Nature. 2016;540(7634):607-610. https://doi.org/10.1038/nature20561
- Vannini A. A structural perspective on RNA polymerase I and RNA polymerase III transcription machineries. Biochim Biophys Acta. 2013;1829(3-4):258-264. https://doi.org/10.1016/j.bbagrm.2012.09.009
- Hopper AK, Nostramo RT. tRNA Processing and subcellular trafficking proteins multitask in pathways for other RNAs. Front Genet. 2019;10:96. https://doi.org/10.3389/fgene.2019.00096
- Keene JD. Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome. Proc Natl Acad Sci U S A. 2001;98(13):7018-7024. https://doi.org/10.1073/pnas.111145598